Neonatal surfactant therapy beyond respiratory distress syndrome.
Dargaville PA, Herting E, Soll RF.
Semin Fetal Neonatal Med. 2023 Dec;28(6):101501. doi: 10.1016/j.siny.2023.101501. Epub 2023 Nov 23.
Surfactant therapy in late preterm and term neonates with respiratory distress syndrome: a systematic review and meta-analysis.
Ramaswamy VV, Abiramalatha T, Bandyopadhyay T, Boyle E, Roehr CC.
Arch Dis Child Fetal Neonatal Ed. 2022 Jul;107(4):393-397. doi: 10.1136/archdischild-2021-322890. Epub 2021 Oct 22.
Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study).
Corsini I, Rodriguez-Fanjul J, Raimondi F, Boni L, Berardi A, Aldecoa-Bilbao V, Alonso-Ojembarrena A, Ancora G, Aversa S, Beghini R, Meseguer NB, Capasso L, Chesi F, Ciarcià M, Concheiro A, Corvaglia L, Ficial B, Filippi L, Carballal JF, Fusco M, Gatto S, Ginovart G, Gregorio-Hernández R, Lista G, Sánchez-Luna M, Martini S, Massenzi L, Miselli F, Mercadante D, Mosca F, Palacio MT, Perri A, Piano F, Prieto MP, Fernandez LR, Risso FM, Savoia M, Staffler A, Vento G, Dani C.
Trials. 2023 Nov 4;24(1):706. doi: 10.1186/s13063-023-07745-8.
Randomized Trial of Surfactant Therapy via Laryngeal Mask Airway Versus Brief Tracheal Intubation in Neonates Born Preterm.
Gallup JA, Ndakor SM, Pezzano C, Pinheiro JMB.
J Pediatr. 2023 Mar;254:17-24.e2. doi: 10.1016/j.jpeds.2022.10.009. Epub 2022 Oct 12.
Use of surfactant beyond respiratory distress syndrome, what is the evidence?
Desai RK, Yildiz Atar H, Lakshminrusimha S, Ryan RM.
J Perinatol. 2024 Apr;44(4):478-487. doi: 10.1038/s41372-024-01921-7. Epub 2024 Mar 8.
Timing of surfactant treatment in respiratory distress syndrome.
van Kaam AH, Niemarkt HJ, Onland W.
Semin Fetal Neonatal Med. 2023 Dec;28(6):101495. doi: 10.1016/j.siny.2023.101495. Epub 2023 Nov 22.
Surfactant status assessment and personalized therapy for surfactant deficiency or dysfunction.
De Luca D, Loi B, Tingay D, Fiori H, Kingma P, Dellacà R, Autilio C.
Semin Fetal Neonatal Med. 2023 Dec;28(6):101494. doi: 10.1016/j.siny.2023.101494. Epub 2023 Nov 23.
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, Cetinkaya M, Kornhauser-Cerar L, Derrick M, Özkan H, Hulzebos CV, Schmölzer GM, Aiyappan A, Lemyre B, Kuo S, Rajadurai VS, O'Shea J, Biniwale M, Ramanathan R, Kushnir A, Bader D, Thomas MR, Chakraborty M, Buksh MJ, Bhatia R, Sullivan CL, Shinwell ES, Dyson A, Barker DP, Kugelman A, Donovan TJ, Goss KCW, Tauscher MK, Murthy V, Ali SKM, Clark HW, Soll RF, Johnson S, Cheong JLY, Carlin JB, Davis PG; OPTIMIST-A Trial Investigators.
JAMA. 2023 Sep 19;330(11):1054-1063. doi: 10.1001/jama.2023.15694.
Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?
Kakkilaya V, Gautham KS.
Pediatr Res. 2023 Apr;93(5):1188-1198. doi: 10.1038/s41390-022-02265-8. Epub 2022 Aug 19.
Surfactant replacement therapy.
Stevens TP, Sinkin RA.
Chest. 2007 May;131(5):1577-82. doi: 10.1378/chest.06-2371.
